Clinical Trials Logo

White Blood Cell clinical trials

View clinical trials related to White Blood Cell.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03376698 Completed - Clinical trials for Coronary Artery Disease

Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease

DRC-04
Start date: June 15, 2017
Phase: Phase 2
Study type: Interventional

This study is designed to investigate dose-dependent effects of low dose colchicine on inflammatory responses, endothelial function in type 2 diabetic patients with coronary artery disease and leukocyte activation. This study also tested the relationship between doses and safety issue such as incidence of diarrhea. Eligible patients will be randomly allocated to three treatment group: colchicine at 0.5mg per day, 0.25mg per day or placebo for 12 weeks in a double blind , parallel group design. High sensitive-CRP at 4 weeks as primary end point and flow mediated vasodilatation at 12 weeks as the secondary end point will be measured.